News | Naveris Cancer Blood Test

Filter

All News Press Release Publications

Naveris’ Head and Neck Cancer Recurrence Detection Study Selected for Presentation at ASTRO 2022 Plenary Session

Natick Company Develops Test to Detect Head and Neck Cancer that Could Lead to Earlier Diagnosis

New Saliva Test Detects Head and Neck Cancer

Naveris, Inc. Raises $19 Million in Financing to Advance and Commercialize Blood Tests for Early Detection of HPV and Other Viral-Related Cancers

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch

Blood Test Accurately Identifies HPV-related Head and Neck Cancer Recurrence; Prospective Clinical Study Published in Journal of Clinical Oncology

Study finds blood test accurately tracks HPV-linked head and neck cancer

Researchers identify traits linked to better outcomes in HPV-linked head and neck cancer

Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer

Biomarker blood test accurately confirms remission in patients with HPV-associated oral cancer

Blood Test Confirms Remission in HPV-Associated Oral Cancer Patients

Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer